Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Schott von Romer
K. Schott von Romer
non-small cell lung cancer (NSCLC)
Pathology
Chemotherapy
Medicine
Performance status
3
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sequencing of single-agent (SA) docetaxel (T) and gemcitabine (G) therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of three consecutive randomized trials
2016
Journal of Clinical Oncology
C. Manegold
Nick Thatcher
C. Kortsik
G. Koschel
J. Mezger
K. Schott von Romer
Lothar Pilz
Show All
Source
Cite
Save
Citations (3)
Clinical prognostic factors in advanced non-small cell lung cancer (NSCLC): Cox regression analysis based on 789 patients treated in three consecutive randomized trials
2007
Journal of Clinical Oncology
Lothar Pilz
Nick Thatcher
Cornelius Kortsik
G. Koschel
J. Mezger
K. Schott von Romer
C. Manegold
Show All
Source
Cite
Save
Citations (0)
Biomarker analysis from TRUST, a trial of erlotinib in non-small cell lung cancer (NSCLC)
2007
Journal of Clinical Oncology
Claus Peter Schneider
K. Schott von Romer
Sylvia Gütz
B. Raack
R. Dierkesmann
Eckart Laack
W. Guschall
A. Schmittel
Ulrich Gatzemeier
Show All
Source
Cite
Save
Citations (7)
1